For: | Zheng Q, Qiu WC, Yan J, Wang WG, Yu S, Wang ZG, Ai KX. Prokinetic effects of a ghrelin receptor agonist GHRP-6 in diabetic mice. World J Gastroenterol 2008; 14(30): 4795-4799 [PMID: PMC2739343 DOI: 10.3748/wjg.14.4795] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i30/4795.htm |
Number | Citing Articles |
1 |
Beverley Greenwood-Van Meerveld, Michael Kriegsman, Richard Nelson. Ghrelin as a target for gastrointestinal motility disorders. Peptides 2011; 32(11): 2352 doi: 10.1016/j.peptides.2011.03.014
|
2 |
B. Avau, F. Carbone, J. Tack, I. Depoortere. Ghrelin signaling in the gut, its physiological properties, and therapeutic potential. Neurogastroenterology & Motility 2013; 25(9): 720 doi: 10.1111/nmo.12193
|
3 |
Ehsan N. Mohammadi, Claudio Pietra, Claudio Giuliano, Li Fugang, Beverley Greenwood-Van Meerveld. A Comparison of the Central versus Peripheral Gastrointestinal Prokinetic Activity of Two Novel Ghrelin Mimetics. The Journal of Pharmacology and Experimental Therapeutics 2019; 368(1): 116 doi: 10.1124/jpet.118.250738
|
4 |
Irinel Popescu, Phillip R. Fleshner, John C. Pezzullo, Philippa A. Charlton, Gordana Kosutic, Anthony J. Senagore. The Ghrelin Agonist TZP-101 for Management of Postoperative Ileus After Partial Colectomy: A Randomized, Dose-Ranging, Placebo-Controlled Clinical Trial. Diseases of the Colon & Rectum 2010; 53(2): 126 doi: 10.1007/DCR.0b013e3181b54166
|
5 |
Betty De Smet, Anna Mitselos, Inge Depoortere. Motilin and ghrelin as prokinetic drug targets. Pharmacology & Therapeutics 2009; 123(2): 207 doi: 10.1016/j.pharmthera.2009.04.004
|
6 |
Jing Ma, Christopher K. Rayner, Karen L. Jones, Michael Horowitz. Diabetic Gastroparesis. Drugs 2009; 69(8): 971 doi: 10.2165/00003495-200969080-00003
|
7 |
Hanaa S. Sallam, Jiande D. Z. Chen. The Prokinetic Face of Ghrelin. International Journal of Peptides 2010; 2010: 1 doi: 10.1155/2010/493614
|
8 |
Weihua Liu, Xiaoyan Zhang, Peiqing Liu, Xiaoyan Shen, Tian Lan, Wenyuan Li, Qin Jiang, Xi Xie, Heqing Huang. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury. European Journal of Pharmacology 2010; 638(1-3): 150 doi: 10.1016/j.ejphar.2010.04.033
|
9 |
Carl Johan Drott, Petra Franzén, Per-Ola Carlsson. Ghrelin in rat pancreatic islets decreases islet blood flow. American Journal of Physiology-Endocrinology and Metabolism 2019; 317(1): E139 doi: 10.1152/ajpendo.00004.2019
|
10 |
R.S. Somani, P.R. Deshmukh, P.R. Shah, R.M. Soni, D.P. Jain, S.S. Khaserao. Prokinetic Effect of Hyponidd, a Herbomineral Formulation in STZ- Induced Diabetic Rats. Pharmacologia 2013; 4(1): 48 doi: 10.5567/pharmacologia.2013.48.52
|
11 |
Anwarbaig C. Mirza, Shital S. Panchal, Ahmed A. Allam, Sarah I. Othman, Milan Satia, Sanjay N. Mandhane. Syringic Acid Ameliorates Cardiac, Hepatic, Renal and Neuronal Damage Induced by Chronic Hyperglycaemia in Wistar Rats: A Behavioural, Biochemical and Histological Analysis. Molecules 2022; 27(19): 6722 doi: 10.3390/molecules27196722
|